Kestra Private Wealth Services, LLC Vertex Pharmaceuticals Inc Transaction History

Kestra Private Wealth Services, LLC

$5.3 Billion
Q3 2024

A detailed history of Kestra Private Wealth Services, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Kestra Private Wealth Services, LLC holds 12,861 shares of VRTX stock, worth $5.97 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

12,861

Previous 11,849 8.54%

Holding current value

$5.97 Million

Previous $5.55 Million 7.71%

% of portfolio

0.11%

Previous 0.11%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$460.0 - $505.78 $465,520 - $511,849	1,012 Added 8.54%	12,861 $5.98 Million
Q2 2024 Aug 12, 2024	BUY	$392.81 - $485.53 $2.14 Million - $2.65 Million	5,448 Added 85.11%	11,849 $5.55 Million
Q1 2024 May 02, 2024	BUY	$407.69 - $446.08 $834,541 - $913,125	2,047 Added 47.01%	6,401 $2.68 Million
Q4 2023 Feb 05, 2024	BUY	$343.0 - $410.68 $394,450 - $472,282	1,150 Added 35.89%	4,354 $1.77 Million
Q3 2023 Nov 07, 2023	BUY	$338.18 - $362.46 $467,026 - $500,557	1,381 Added 75.75%	3,204 $1.11 Million
Q2 2023 Aug 08, 2023	BUY	$314.42 - $351.91 $88,037 - $98,534	280 Added 18.15%	1,823 $641,000
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $54,946 - $62,681	194 Added 14.38%	1,543 $486,000
Q4 2022 Jan 31, 2023	SELL	$285.76 - $321.48 $2,286 - $2,571	-8 Reduced 0.59%	1,349 $389,000
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $7,941 - $8,860	-29 Reduced 2.09%	1,357 $393,000
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $22,791 - $28,377	-97 Reduced 6.54%	1,386 $391,000
Q1 2022 May 26, 2022	SELL	$221.42 - $260.97 $9,299 - $10,960	-42 Reduced 2.75%	1,483 $387,000
Q4 2021 Jan 21, 2022	BUY	$177.01 - $223.45 $70,272 - $88,709	397 Added 35.2%	1,525 $334,000
Q3 2021 Oct 21, 2021	SELL	$181.39 - $202.99 $52,240 - $58,461	-288 Reduced 20.34%	1,128 $204,000
Q2 2021 Jul 30, 2021	BUY	$187.49 - $221.1 $14,624 - $17,245	78 Added 5.83%	1,416 $285,000
Q1 2021 May 11, 2021	BUY	$207.02 - $241.31 $276,992 - $322,872	1,338 New	1,338 $287,000
Q4 2020 Jan 21, 2021	SELL	$207.01 - $276.09 $170,783 - $227,774	-825 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$255.65 - $303.1 $210,911 - $250,057	825 New	825 $224,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Private Wealth Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Private Wealth Services, LLC with notifications on news.

Account

Kestra Private Wealth Services, LLC Vertex Pharmaceuticals Inc Transaction History